EBS – emergent biosolutions inc. (US:NASDAQ)
Stock Stats
News
Lyophilization Services for Biopharmaceuticals Industry Research Report 2024-2033: Drivers and Restraints, Competitive Landscape, Future Opportunities and Strategies [Yahoo! Finance]
Emergent BioSolutions Inc. (NYSE: EBS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 [Yahoo! Finance]
Emergent BioSolutions Inc. (NYSE: EBS) had its price target raised by analysts at Benchmark Co. from $8.00 to $12.00. They now have a "buy" rating on the stock.
Form 3 Emergent BioSolutions For: Nov 18 Filed by: Lowry Simon C
Form 4 Emergent BioSolutions For: Nov 12 Filed by: DeGolyer Donald W
Form 4 Emergent BioSolutions For: Nov 11 Filed by: Hartzel William
Form 4 Emergent BioSolutions For: Nov 11 Filed by: White Marvin L
Form SC 13G Emergent BioSolutions Filed by: OAK HILL ADVISORS LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.